drugset / Trial / NCT04784910
Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The study aims to demonstrate the preventive effect of DWP14012 20 mg for peptic ulcer is non-inferior to that of Lansoprazole 15 mg in terms of prevention of peptic ulcer and confirm the safety of DWP14012 20 mg.
Timeline
- Start
- 2021-05-21
- Primary completion
- 2023-11-27
- Completion
- 2023-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABEPRAZAN | Small molecule | 20 mg | Oral |
| Comparator | Lansoprazole 15 mg | Unknown | 15 mg | Oral |